Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04591977 · ClinicalTrials.gov registry record · NA

Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments

A NA study, sponsored by Milton S. Hershey Medical Center.

Terminated
Registry status
NA
Development phase
46
Enrollment target

NCT04591977 is a NA study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 46 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04591977, a NA study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.

TERMINATED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This study seeks to compare the accuracy and acceptability of Human Papillomavirus (HPV) testing self-sampling kit versus standard clinician-sampled HPV testing for cervical cancer screening. The primary outcome of this study is the concordance between screening results on self-sampling kits compared to clinician-collected HPV test and Pap smear results. Secondary endpoints will include acceptability of self-sampling and barriers to cervical cancer screening. These endpoints will be analyzed to try to circumvent barriers to the cervical cancer screening and ascertain whether self-sampling is a viable alternative to clinician sampling.

Interventions

  • DEVICE HPV Self-Sampling Kit (Evalyn Brush)

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2021-01-07
Est. Completion 2022-11-10
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT04591977

The ClinicalTrials.gov registry entry for NCT04591977 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HPV Self-Sampling Kit (Evalyn Brush) is the first listed.

NCT04591977 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04591977 about?

NCT04591977 is a clinical study titled "Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments". This study seeks to compare the accuracy and acceptability of Human Papillomavirus (HPV) testing self-sampling kit versus standard clinician-sampled HPV testing for cervical cancer screening. The primary outcome of this study is the concordance between screening results on self-sampling kits compare...

What is the current status of trial NCT04591977?

This trial is currently terminated. It is a NA study. The enrollment target is 46 participants. The study started on 2021-01-07. Estimated completion is 2022-11-10.

What interventions are being tested in trial NCT04591977?

The interventions under investigation include: HPV Self-Sampling Kit (Evalyn Brush) (DEVICE).

Who is sponsoring clinical trial NCT04591977?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.